• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207

Professional Introduction to 4,4'-Oxybis((bromomethyl)benzene) (CAS No. 4542-75-0)

4,4'-Oxybis((bromomethyl)benzene), identified by its Chemical Abstracts Service (CAS) number 4542-75-0, is a significant compound in the realm of organic synthesis and pharmaceutical chemistry. This bidentate aromatic diamine derivative features two bromomethyl substituents linked by a methoxy bridge, making it a versatile intermediate in the synthesis of complex molecules. Its unique structural properties have garnered attention in recent years due to its potential applications in drug development, material science, and catalysis.

The compound’s molecular structure consists of a central benzene ring with two bromomethyl groups attached at the 1,4-positions and a methoxy group connecting these two aromatic rings. This configuration imparts remarkable reactivity, allowing for facile participation in nucleophilic substitution reactions, cross-coupling reactions, and polymerization processes. The presence of both electrophilic bromomethyl groups and a nucleophilic methoxy group makes it an invaluable building block for constructing more intricate molecular architectures.

In the context of pharmaceutical research, 4,4'-Oxybis((bromomethyl)benzene) has been explored as a precursor for the synthesis of biologically active molecules. Its ability to undergo selective functionalization has enabled the development of novel therapeutic agents targeting various diseases. For instance, researchers have leveraged its reactivity to introduce pharmacophoric groups that modulate biological pathways relevant to cancer therapy, inflammation, and neurodegenerative disorders. Recent studies have highlighted its role in generating Schiff bases and heterocyclic compounds with potential antimicrobial and anti-inflammatory properties.

The compound’s utility extends beyond drug discovery into the realm of advanced materials. Its bifunctional nature allows for the creation of polymers with tailored properties, such as cross-linked networks or conductive polymers. In polymer chemistry, 4,4'-Oxybis((bromomethyl)benzene) serves as a monomer or cross-linking agent to develop materials with enhanced mechanical strength, thermal stability, or chemical resistance. These advancements are particularly relevant in industries requiring high-performance materials for applications ranging from aerospace to electronics.

Recent advancements in synthetic methodologies have further expanded the applications of CAS No 4542-75-0. Transition-metal-catalyzed reactions, such as palladium-catalyzed cross-coupling reactions, have been employed to introduce additional functional groups or to construct more complex molecular frameworks. These techniques have enabled the synthesis of macrocyclic compounds and dendrimers that exhibit unique physicochemical properties. Moreover, green chemistry approaches have been explored to optimize the synthesis of this compound while minimizing environmental impact.

The pharmaceutical industry has shown particular interest in derivatives of 4,4'-Oxybis((bromomethyl)benzene) due to their potential as kinase inhibitors and receptor modulators. Kinases play a crucial role in cell signaling pathways associated with numerous diseases, making them attractive targets for therapeutic intervention. By modifying the substituents on this compound’s core structure, researchers can fine-tune its binding affinity and selectivity for specific kinases. Preliminary clinical trials have demonstrated promising results in preclinical models for certain kinase-driven cancers.

In material science, the compound’s ability to form stable coordination complexes with transition metals has been exploited for catalytic applications. These metal complexes exhibit enhanced reactivity in various organic transformations, including hydrogenation and oxidation reactions. Such catalytic systems are essential for industrial processes that require high efficiency and selectivity. The development of sustainable catalytic methods aligns with global efforts to reduce reliance on traditional petrochemical feedstocks.

The synthesis and handling of CAS No 4542-75-0 require careful consideration due to its reactive nature. While it is not classified as a hazardous material under standard regulations, proper safety protocols must be followed to prevent unintended side reactions or exposure risks. Researchers often employ controlled reaction conditions and inert atmospheres to ensure optimal yields and product purity. Advances in automation and process analytical technology (PAT) have improved the reproducibility and scalability of its synthesis.

Future research directions for 4,4'-Oxybis((bromomethyl)benzene) include exploring its role in photodynamic therapy (PDT) and developing novel photoactive materials. Its ability to form stable metal complexes with photosensitizing properties makes it a candidate for generating reactive oxygen species that can selectively target diseased cells. Additionally, investigations into its behavior under different environmental conditions may uncover new applications in nanotechnology and smart materials.

In conclusion,4,4'-Oxybis((bromomethyl)benzene) (CAS No 4542-75-0) is a multifaceted compound with broad applications across pharmaceuticals、materials science，and catalysis。Its unique structural features enable diverse functionalizations，making it an indispensable tool for synthetic chemists。As research continues，the potential uses of this compound are expected to expand，driving innovation across multiple scientific disciplines。

• 2746-25-0(4-Methoxybenzyl bromide)
• 877-88-3(3,5-Dimethoxybenzyl bromide)
• 874-98-6(3-Methoxybenzyl bromide)
• 19254-79-6(1,3-bis(Bromomethyl)-5-methoxy-Benzene)
• 73022-40-9(2-(Bromomethyl)-6-methoxynaphthalene)
• 51632-16-7(1-(Bromomethyl)-3-phenoxybenzene)
• 496853-18-0(Methylium, bromo(4-methoxyphenyl)-)
• 36881-42-2(1-(Bromomethyl)-4-phenoxybenzene)
• 103143-23-3(2-(Bromomethyl)-7-methoxynaphthalene)
• 106116-42-1(1-(Bromomethyl)-3-methoxy-5-methylbenzene)